...
首页> 外文期刊>Molecular Biology Reports >Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients
【24h】

Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients

机译:COPD患者肺动脉高压中内皮型一氧化氮合酶A / B,血管紧张素转化酶I / D和血清素转运蛋白L / S基因多态性的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Different biochemical pathways and cellular mechanisms play role in the pathogenesis of pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD). Alveolar hypoxia is not the only determinant of vascular remodeling, genetic factors are thought to have additive effects. We aimed to investigate the effects of endothelial nitric oxide synthase (eNOS A/B), angiotensin converting enzyme (ACE I/D) and serotonin transporter (5-HTT L/S) gene polymorphisms on development and severity of PH in COPD patients. 50 COPD patients without PH (group 1); 30 COPD patients with PH confirmed with echocardiography (group 2) and 49 healthy subjects (group 3) as control group were included to the study. eNOS A/B, ACE I/D and 5-HTT L/S gene polymorphisms and allele frequencies of COPD patients with and without PH and healthy subjects were determined. Functional parameters and echocardiographic measurements were recorded. Patients with PH were also assessed in two subgroups according to the severity of pulmonary arterial pressure (PAP). Significant differences among three groups in the distribution of 5-HTT genotype and allele frequency were present (respectively p = 0.002; p = 0.021). In group 2, LL and LS genotype rate was 93.3 % with a frequency of 71.2 % L allele and 28.3 % of S allele. 5-HTT LL genotype was present in 88.9 % of patients with PAP ≥50 mmHg significantly (p = 0.012). Other genotype distributions were not significantly different between two subgroups. The results of this study can suggest that COPD patients with L allele of 5-HTT may have higher risk for the development of PH and patients with LL genotype of 5-HTT may present higher PAP. We also demonstrated that eNOS and ACE gene polymorphisms were not associated with the development and severity of PH in our study population. Further studies with larger numbers of patients are needed to explore these relationships.
机译:在慢性阻塞性肺疾病(COPD)中肺动脉高压(PH)的发病机理中,不同的生化途径和细胞机制均起作用。肺泡缺氧不是血管重塑的唯一决定因素,遗传因素被认为具有累加作用。我们旨在研究内皮型一氧化氮合酶(eNOS A / B),血管紧张素转化酶(ACE I / D)和血清素转运蛋白(5-HTT L / S)基因多态性对COPD患者PH的发展和严重程度的影响。 50例无PH的COPD患者(第1组); 30例经超声心动图确诊的COPD PH患者(第2组)和49例健康受试者(第3组)作为对照组被纳入研究。确定有无PH的COPD患者和健康受试者的eNOS A / B,ACE I / D和5-HTT L / S基因多态性和等位基因频率。记录功能参数和超声心动图测量值。还根据肺动脉压(PAP)的严重程度将PH患者分为两个亚组。三组在5-HTT基因型分布和等位基因频率上存在显着差异(分别为p = 0.002; p = 0.021)。在第2组中,LL和LS基因型率为93.3%,L等位基因频率为71.2%,S等位基因频率为28.3%。 PAP≥50mmHg的患者中,有88.9%的患者存在5-HTT LL基因型(p = 0.012)。其他基因型分布在两个亚组之间没有显着差异。这项研究的结果可以表明,患有5-HTT L等位基因的COPD患者发生PH的风险更高,而患有5-HTT LL基因型的COPD患者的PAP更高。我们还证明,在我们的研究人群中,eNOS和ACE基因多态性与PH的发展和严重程度无关。需要对更多患者进行进一步研究以探索这些关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号